Great West Life Assurance CO Stoke Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 10,043 shares of STOK stock, worth $139,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,043
Previous 2,436
312.27%
Holding current value
$139,396
Previous $33,000
309.09%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STOK
# of Institutions
121Shares Held
53.7MCall Options Held
14KPut Options Held
8.8K-
Skorpios Trust8.91MShares$124 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$75.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.72MShares$65.5 Million4.16% of portfolio
-
Baker Bros. Advisors LP New York, NY4.37MShares$60.6 Million0.78% of portfolio
-
Rtw Investments, LP New York, NY4.22MShares$58.6 Million0.95% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $547M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...